11 December 2008
Recently, Steven J. Law, Chief Legal Officer and General Counsel of the U.S. Chamber of Commerce, joined CFIF‘s Renee Giachino to discuss the deceptively-named Employee Free Choice Act (EFCA), how its passage would upend decades of settled labor law and increase the risk of coercion to employees
0:00 0:00

Related Podcasts

Healthcare Takeaways from the One Big Beautiful Bill, By the Numbers
25 July 2025
Sally Pipes, Founder, CEO and President of the Pacific Research Institute, discusses the biggest healthcare takeaways from a numbers perspective in the recently enacted “Big Beautiful Bill,” how cheap drugs from Canada can’t make America healthy, and the real culprit impeding drug competition.
One Big Beautiful Megabill Faces Mega Obstacles
26 June 2025
Thomas Aiello, Senior Director of Government Affairs at the National Taxpayers Union, discusses the uphill battle President Trump’s “Big Beautiful Bill” is facing on Capitol Hill, the looming July 4th deadline, and how the battle in the Senate may ultimately result in improvements to the House version of the bill.
Secret Service Vulnerabilities and the Future of U.S. Politics
02 August 2024
Virginia Allen, Senior News Producer and Podcast Host at The Daily Signal, discusses the resignation of Secret Service Director Kimberly Cheatle, vulnerabilities exposed by the assassination attempt of former President Trump, and what the future of American politics may look like.
The Assault on American Energy
25 August 2023
Phil Kerpen, Founder and President of American Commitment, discusses public policy's impact on energy costs and accessibility, how the onslaught of regulations and hostility toward fossil fuels mean negative consequences far beyond the gas pump, and why Bidenomics is having a disastrous effect on consumer choice.
The Biden Administration's Nonsensical Assault on Noncompete Clauses
02 February 2023
Timothy Lee, Senior Vice President of Legal and Public Affairs, discusses the Federal Trade Commission's ill-advised push to ban noncompete clauses.
Drug Price Controls Would Come With Big Costs
29 July 2022
Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the potential real world costs of prescription drug price controls, including lost lives, shortages and innovation disincentives, and how drug prices are weathering the inflation storm.